person Sign In / Create Account

Multiple Myeloma Bispecific Antibody Talquetamab Update

Myeloma News — June 23, 2022

New data from a new bispecific antibody targeting GPR5CD called talquetamab is now available.

A Redefined Life: Clare's Perspective on Myeloma Survivorship

Melflufen Receives European Medicines Agency (EMA) Positive Opinion as Myeloma Treatment

Current Status of Three Popular Patient Assistance Programs

Upcoming Events

Jun 27, 2022 / 02:00PM - 03:00PM CDT

Allo CAR T Myeloma Therapies with Jesus Berdeja, MD, Sarah Cannon Research Institute

HealthTree Podcast for Multiple Myeloma

View details chevron_right

Jun 28, 2022 / 06:30PM - 08:00PM EDT

The Mental Journey of Myeloma

Florida Myeloma Community Chapter

View details chevron_right

Jun 29, 2022 / 06:30PM - 08:20PM EDT

A LIVE Screening of the Forks Over Knives Documentary- with a Q&A!

Nutrition and Wellness for Myeloma Chapter

View details chevron_right

Jul 12, 2022 / 06:30PM - 08:00PM PDT

SoCal Myeloma Community: How to Live WITH Myeloma While Not Dying from Something Else

SoCal Myeloma Community Chapter

View details chevron_right

View all events

HealthTree Moves for Myeloma Columbus, Ohio 5k and 1M Race

Life with Myeloma—June 22, 2022

The HealthTree Moves for Myeloma Columbus, Ohio race was a fabulous event to get together and raise funds for myeloma research.

Updated Teclistamab Results in Multiple Myeloma

Myeloma News—June 17, 2022

The bispecific antibody teclistamab is getting closer to FDA approval for multiple myeloma patients. Here's updated data from recent myeloma conferences.

Juneteenth and Multiple Myeloma

Life with Myeloma—June 16, 2022

What is Juneteenth? HealthTree Foundation for Multiple Myeloma is celebrating in a Juneteenth Virtual Tour

The Dawning Era of Bispecific Antibodies in Myeloma

Myeloma News—June 14, 2022

The flood of bispecific antibodies is coming, with new data emerging from the recent EHA meeting

Infection Prevention for Myeloma Patients

Life with Myeloma—June 13, 2022

Learn from a specialist why infections are so serious in multiple myeloma and what you can do to prevent the most dangerous.

Myeloma News

Multiple Myeloma Bispecific Antibody Talquetamab Update Melflufen Receives European Medicines Agency (EMA) Positive Opinion as Myeloma Treatment Updated Teclistamab Results in Multiple Myeloma

Life with Myeloma

A Redefined Life: Clare's Perspective on Myeloma Survivorship Current Status of Three Popular Patient Assistance Programs HealthTree Moves for Myeloma Columbus, Ohio 5k and 1M Race

HealthTree Podcast for Myeloma

Full Show: Looking Forward into 2022 in Multiple Myeloma With Robert Orlowski, MD, PHD, MD Anderson Cancer Center Full Show: Engineered Toxin Bodies Targeting CD38 in Myeloma with Shaji Kumar, MD, Mayo Clinic Full Show: Tasquinimod As a New Myeloma Therapy with Dan Vogl, MD and Yulia Nefedova, MD, PhD

MC Events

The Relationship Between Inflammation and Myeloma How To Live with Myeloma Without Defining Yourself By It How to Determine Whether or Not a Stem Cell Transplant is Successful with Dr. Guido Tricot

Myeloma Clinical Trials

Clinical Trial: Can Yoga Help Alleviate Peripheral Neuropathy After Chemo? Clinical Trial: A New Myeloma Therapy Tasquinimod Targeting MDSCs Debunking Clinical Trial Myths with Dr. Craig Cole

Myeloma 101

Velcade and Green Tea: A Myeloma No-No Multiple Myeloma and the 4;14 Translocation What to Ask Your Doctor at Your First Multiple Myeloma Appointment

Upcoming MC Round Tables

Myeloma Crowd Round Table in Berlin, Germany on June 4

Myeloma Coach

Goals, Silver Linings & Survivorship with Multiple Myeloma The Mental Battle of Myeloma Understanding the Nuances of Medicare Can Save you Money and Heartache

HealthTree University

All About CARVYKTI for Multiple Myeloma How Can I Improve My Immune System With Multiple Myeloma? What are Bispecific Antibodies and How are They Used in Treating Multiple Myeloma?

Thanks to our HealthTree Community for Myeloma Sponsors:

The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811

Multiple Myeloma Bispecific Antibody Talquetamab Update

Upcoming Events

Jun 27, 2022 / 02:00PM - 03:00PM CDT

Allo CAR T Myeloma Therapies with Jesus Berdeja, MD, Sarah Cannon Research Institute

Jun 28, 2022 / 06:30PM - 08:00PM EDT

The Mental Journey of Myeloma

Jun 29, 2022 / 06:30PM - 08:20PM EDT

A LIVE Screening of the Forks Over Knives Documentary- with a Q&A!

Jul 12, 2022 / 06:30PM - 08:00PM PDT

SoCal Myeloma Community: How to Live WITH Myeloma While Not Dying from Something Else

HealthTree Moves for Myeloma Columbus, Ohio 5k and 1M Race

Updated Teclistamab Results in Multiple Myeloma

Juneteenth and Multiple Myeloma

The Dawning Era of Bispecific Antibodies in Myeloma

Infection Prevention for Myeloma Patients

Myeloma News

Life with Myeloma

HealthTree Podcast for Myeloma

MC Events

Myeloma Clinical Trials

Myeloma 101

Upcoming MC Round Tables

Myeloma Coach

HealthTree University

Get the latest thought leadership on Myeloma delivered straight to your inbox.

Thanks to our HealthTree Community for Myeloma Sponsors:

Follow Us